Performance and Safety Use of the Nanostructured Titanium Dental Implant "KONTACT N"

March 1, 2022 updated by: Biotech Dental

Multicenter, Prospective, Observational Study on the Performance and Safety Use of the Dental Implant "KONTACT N" in the Current Clinical Practice

A multicenter prospective observational study in which aim is to illustrate the clinical outcome of dental implants "Kontact N"; and the effects of its nanostructured surface on the osseointegration and secondary stability without increasing the rate of peri-implantitis. All the enrolled patients will be eligible for one or multiple implant-supported fixed restoration(s) according to the routine clinical practice and the manufacturer's instruction for use.

Study Overview

Study Type

Observational

Enrollment (Actual)

164

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France
        • Dr KHOURY Elias

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Any patient who is eligible and planned for an implant-supported prosthetic restoration following the instructions for use of the KONTACT N implant and who meets the inclusion / exclusion criteria.

Description

Inclusion Criteria:

  • Edentulous patient (partially or completely AND formerly, recently or just before implantation) requiring the placement of one (or more) dental implant (s) in maxillary or mandibular
  • Age ≥ 18 years
  • Good general health (ASA score between [1-2])
  • Sufficient bone volume and quality (with or without bone graft) to support the implant
  • Non-opposition of the patient for the collection of his medical data as part of the study (delivery of a patient's sheet)

Exclusion Criteria:

  1. Poor oral hygiene
  2. Bruxism, parafunctional habits, occlusion disorders and / or temporomandibular joints
  3. Infections and oral inflammation such as periodontitis, gingivitis
  4. Patient with metabolic disorders (eg diabetes mellitus) or bone disease that may compromise peri-implant tissue healing
  5. Heavy smoker (> 10 cigarettes / day)
  6. Patient with a pathology or immunosuppressive therapy such as chemotherapy, radiotherapy
  7. Patient on prolonged steroid therapy
  8. Titanium / titanium alloy allergy
  9. Alcohol or drug abuse
  10. Pregnant woman (or likely to be pregnant); or breastfeeding
  11. Difficulty of medical follow-up patients with geographical, social or psychological constraints
  12. Persons deprived of liberty or guardianship
  13. Involuntary / patient refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant success rate
Time Frame: up to 12 months post-implantation
Rate of implants still in function up to 12 months post-implantation and which fulfill all the predefined success criteria in the protocol.
up to 12 months post-implantation
Peri-implantitis rate
Time Frame: 12 months post-implantation
Peri-implantitis is an inflammatory process affecting the tissues around the implant and causing loss of bone support (diagnosed by radiographic and clinical assessment).
12 months post-implantation
Mean osseointegration period
Time Frame: From the implantation up to 12 months
Period from which a direct structural and functional junction can be observed between the remodeled living bone and the implant surface (by clinical and radiographic assessment).
From the implantation up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: KHOURY, Dr

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 4, 2019

Primary Completion (ACTUAL)

September 5, 2020

Study Completion (ACTUAL)

January 13, 2022

Study Registration Dates

First Submitted

June 15, 2018

First Submitted That Met QC Criteria

July 10, 2018

First Posted (ACTUAL)

July 11, 2018

Study Record Updates

Last Update Posted (ACTUAL)

March 2, 2022

Last Update Submitted That Met QC Criteria

March 1, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Implant

Clinical Trials on dental implant (KONTACT N)

Subscribe